Wed.Nov 20, 2024

article thumbnail

STAT+: AI in drug discovery is ‘nonsense,’ but call Schrödinger ‘AI’ if you want, says CEO

STAT

Schrödinger CEO Ramy Farid wants you to know that his company isn’t an AI company…but he’ll call it that if you want to. The company, founded in 1990, started out by making software that used the basic laws of physics to laboriously and exactly predict how molecules will interact with each other in space. Those calculations, rooted in the field of computational physics, needed lots of expensive and time-consuming computing power to run, and many people abandoned those t

article thumbnail

Latest UKHSA figures show rise in both antibiotic use and resistance

The Pharmacist

Antibiotic use rose by 2.4% year-on-year in 2023 and prescribing levels are now in line with those seen in 2019, according to national surveillance data published by the UK Health Security Agency (UKHSA). The increases were seen across the majority of antibiotic groups, with penicillins accounting for the most frequently prescribed antibiotic group in primary […] The post Latest UKHSA figures show rise in both antibiotic use and resistance appeared first on The Pharmacist.

111
111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: RFK Jr. is exploring a plan to upend Medicare’s physician payments system

STAT

WASHINGTON  — People close to Robert F. Kennedy Jr. are exploring a proposal that could upend how physician payment is determined in America, four sources familiar with the process told STAT.

363
363
article thumbnail

Lupin launches Bumetanide injection USP in the United States

Express Pharma

On 19 November 2024, Lupin announced the launch of Bumetanide Injection USP in the United States following approval from the United States Food and Drug Administration (FDA). The product is available in two formulations: 1 mg/4 mL (0.25 mg/mL) single-dose vials and 2.5 mg/10 mL (0.25 mg/mL) multiple-dose vials. Bumetanide Injection USP is a generic equivalent of Bumex Injection (0.25 mg/mL) by Validus Pharmaceuticals, LLC.

105
105
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

AI-guided decisions can devastate lower-income Americans. This group wants to change that

STAT

In 2016, the Arkansas Legal Aid Center was flooded with calls. People on a Medicaid program that provided in-home care assistance were having their caregiving hours cut. Reducing the hours for somebody with quadriplegia or cerebral palsy was devastating, said Kevin De Liban, an attorney with the organization at the time. “People are lying in their own waste, people are getting bed sores from not being turned.

324
324

More Trending

article thumbnail

STAT+: Kura licenses leukemia drug to Japanese drugmaker

STAT

Kura Oncology has signed a global partnership with the Japanese drugmaker Kyowa Kirin to develop and sell Kura’s experimental treatment for acute leukemia, the companies said Wednesday.  Kyowa is paying $320 million to Kura in exchange for global licensing rights to the drug, called ziftomenib, which is in a late-stage clinical trial for a genetically defined type of advanced leukemia.

301
301
article thumbnail

Maximizing ROI in Pharma: The Power of Display Advertising for Targeted Campaigns

Pharma Marketing Network

Table of Contents Sr# Headings 1 Introduction 2 What Is Display Advertising? 3 Why Display Advertising Matters in Pharma 4 Key Benefits of Display Advertising 5 Targeting: Reaching the Right Audience 6 Personalization in Display Ads 7 Case Study: Successful Pharma Display Campaigns 8 Choosing the Right Platforms 9 Metrics to Track for ROI Success 10 Regulatory Challenges and Solutions 11 The Role of Branded Drugs in Display Ads 12 Creative Best Practices for Display Ads 13 Aligning Display Ads w

article thumbnail

STAT+: Doubling down on its strategy, Pfizer names its head of oncology as new research chief

STAT

Pfizer said its chief oncology officer, Chris Boshoff, will head all of the company’s research and development efforts in addition to keeping his current duties overseeing the company’s scientific and commercial efforts in cancer. Boshoff replaces Mikael Dolsten, who led research and development at the drug giant for 15 years and who announced his plans to retire in July.

275
275
article thumbnail

Ardena’s expanded nanomedicine facility granted full GMP approval

Pharma Times

The Netherlands facility is designed to handle a wide range of nanomedicines, including lipid-based nanoparticles

129
129
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Opinion: Paying a visit to ‘Mom & Dad’s Nipple Factory’

STAT

When Randi Johnson was undergoing treatment for breast cancer, her husband, Brian, often felt at a loss to help. But then, when he and Randi met with a surgeon to discuss reconstructing her breast, he was struck by something he could do. The Midwestern father of five, a lifelong tinkerer, decided to make his wife the best possible prosthetic nipple.

265
265
article thumbnail

Flagship, Pfizer alliance yields two more startup deals

BioPharma Dive

Pfizer will work with Ampersand Biomedicines and Montai Therapeutics to find drugs for obesity and lung cancer, respectively, adding to collaborations it previously formed with other Flagship startups.

114
114
article thumbnail

Investors tell Silence Therapeutics to shush 

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Morning. Today, we meet Pfizer’s new chief scientific officer, ponder why the stock for Silence Therapeutics dropped despite promising data, and see that pharma executives aren’t too worried about Robert F.

article thumbnail

Eliminate swivel chair processes to streamline claims management

pharmaphorum

Streamline claims management in the healthcare industry by eliminating swivel chair processes. Learn how healthcare providers and biopharma companies can optimise efficiency.

109
109
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

STAT+: Pharmalittle: We’re reading about Pfizer’s new R&D head, Merck and J&J job cuts in China, and more

STAT

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far, so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not particularly appealing. And what better way to make the time fly than to keep busy.

Hospitals 191
article thumbnail

Inside ESMO 2024: Treatments, trials, and top HCPs on social media

pharmaphorum

Discover the latest treatments, clinical trials, and top healthcare professionals sharing insights on social media from the ESMO 2024 conference. Stay updated on the latest advancements in oncology.

108
108
article thumbnail

Daiichi Sankyo and AstraZeneca’s Enhertu snubbed by UK’s NICE for third time 

Pharmaceutical Technology

The UK’s NICE has rejected a deal for the reimbursement of Daiichi Sankyo and AstraZeneca's breast cancer drug Enhertu for the third time.

102
102
article thumbnail

Sage wilts as Huntington's prospect flunks trial

pharmaphorum

Sage Therapeutics' run of bad news has continued with a failed phase 2 trial of dalzanemdor as a treatment for Huntington's disease

105
105
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Wes Streeting says patients should view data sharing ‘the same as taxes’

Pharmaceutical Technology

UK Health Secretary Wes Streeting outlaid the key shifts needed to fix a “fragmented” NHS at the Jefferies London Healthcare Conference.

98
article thumbnail

MSD says subcutaneous Keytruda matches IV form

pharmaphorum

MSD's subcutaneous formulation of top-selling cancer drug Keytruda was non-inferior to the current intravenous version in a head-to-head trial

105
105
article thumbnail

The Science Behind Generic Drug Development: A Deep Dive

Drug Patent Watch

Generic drug development is a complex process that involves rigorous scientific research and regulatory assessments. The U.S. Food and Drug Administration (FDA) plays a crucial role in ensuring the quality and efficacy of generic drugs through various programs and guidelines.

article thumbnail

EMA’s strategy for speeding up drug approvals in the EU

pharmaphorum

The European Medicines Agency (EMA) has implemented a strategy to accelerate drug approvals in the EU. Learn more about their initiatives and how they are streamlining the process for faster access to medicines.

102
102
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Navigating the Complex Landscape: Key Challenges in Biosimilar Development

Drug Patent Watch

The pharmaceutical industry is constantly evolving, and one of the most exciting areas of growth is the development of biosimilars. These biological products, designed to be highly similar to existing approved biologics, offer the promise of more affordable treatment options for patients. However, the journey from concept to market is fraught with challenges.

article thumbnail

Pfizer bags EU okay for haemophilia drug Hympavzi

pharmaphorum

Pfizer's Hympavzi has become the first once-weekly subcutaneous treatment for people living with severe haemophilia B in the EU

98
article thumbnail

Episode 976: Can 3% (hypertonic) sodium chloride ever be given via a peripheral IV?

Pharmacy Joe

In this episode, I’ll discuss peripheral IV administration of 3% sodium chloride solution. Episode 976: Are there times when 3% (hypertonic) sodium chloride can be given through a peripheral IV? Subscribe on iTunes , Android , or Stitcher Infusions of 3% sodium chloride are routinely recommended to be given through central, not peripheral IV lines. This recommendation is based on the theory that since the osmolarity of 3% sodium chloride exceeds 900 mOsm/L, it puts the patient at risk of thrombo

article thumbnail

NICE blames companies for breakdown in Enhertu talks

pharmaphorum

Discussions aimed at making AstraZeneca and Daiichi Sankyo's Enhertu available to breast cancer patients on the NHS have been abandoned

98
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.